Bone protection by inhibition of microRNA-182

Targeting microRNAs recently shows significant therapeutic promise; however, such progress is underdeveloped in treatment of skeletal diseases with osteolysis, such as osteoporosis and rheumatoid arthritis (RA). Here, we identified miR-182 as a key osteoclastogenic regulator in bone homeostasis and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Nat Commun
Autors principals: Inoue, Kazuki, Deng, Zhonghao, Chen, Yufan, Giannopoulou, Eugenia, Xu, Ren, Gong, Shiaoching, Greenblatt, Matthew B., Mangala, Lingegowda S., Lopez-Berestein, Gabriel, Kirsch, David G., Sood, Anil K., Zhao, Liang, Zhao, Baohong
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173760/
https://ncbi.nlm.nih.gov/pubmed/30291236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-018-06446-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars